Navigation Links
New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
Date:3/10/2008

PALO ALTO, Calif., March 10 /PRNewswire-FirstCall/ -- Varian, Inc. (Nasdaq: VARI) announced today its new XSens(TM) Dual Cold Probe. Designed for use with the Varian NMR System, the new probe is Varian's most sensitive probe for 13C detected NMR experiments.

The XSens Probe offers productivity and data quality enhancements for researchers in pharmaceutical, agricultural, chemical and academic laboratories involved in the characterization of quantity-limited samples of natural products, reaction intermediates, metabolites and trace contaminants.

The new probe dramatically increases 13C sensitivity and reduces acquisition time 100-fold compared to a room temperature (RT) Dual Broadband (DB) probe. It also offers a significantly improved 1H sensitivity, reducing acquisition time for 1H detected experiments 75-fold compared to a RT DB probe. In addition to increasing throughput, the enhanced sensitivity for 13C makes it easier for researchers to take advantage of the simpler spectral information available from 13C experiments.

"The XSens Probe is a significant advance in Cold Probe technology," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "By greatly reducing acquisition times, this probe makes previously time- consuming 13C detected NMR analyses a more practical tool for busy laboratories."

For more technical information about Varian's NMR instrumentation, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Double Resonance Probe for Liquid State NMR Applications From Varian, Inc. Increases Productivity for Routine Analyses
2. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
3. Carl Hull Named President and Chief Operating Officer of Gen-Probe
4. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
7. Gen-Probe to Webcast Three Upcoming Presentations
8. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
9. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
10. New FTMS System From Varian, Inc. Offers Switchable LC and GC Sources and True Triple Quadrupole Capabilities
11. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... -- The Allen Institute for Cell Science has released ... collection of gene edited, fluorescently tagged human induced ... with unprecedented clarity. Distributed through the Coriell Institute ... crucial first step toward visualizing the dynamic organization ... cells healthy and what goes wrong in disease. ...
(Date:11/30/2016)... DIEGO and BEIJING , ... a leading commercial provider of genomic services and solutions ... announced today that it has completed a USD $75 ... Merchants Bank Co., Ltd.,s CMB International Capital Management ( ... Innovation Investment Management Co., Ltd. ("SDIC Innovation") and Shanghai ...
(Date:11/30/2016)... 30, 2016   Merck , a leading science ... into a set of agreements with Evotec AG, whereby ... of genetic reagents such as CRISPR and shRNA libraries. ... offers an accelerated pathway to explore and identify new ... identification of new targets, a process that can be ...
(Date:11/30/2016)... ... November 30, 2016 , ... T3D ... a new orally administered treatment for Alzheimer’s disease (AD), today announced that CEO, ... 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s patients at CTAD ...
Breaking Biology Technology:
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):